Psoriatic Arthritis
Conference Coverage
Psoriatic arthritis treatment: “We’re not doing so well”
MAUI, HAWAII – “Psoriatic arthritis lags behind rheumatoid arthritis, maybe by a decade,” despite current treatments and a treat-to-target...
Conference Coverage
VIDEO: PPACMAN aims to advance the combined rheum-derm clinic approach in the community
SAN DIEGO - The idea behind starting PPACMAN the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Networkwas to form clinics at...
Conference Coverage
Could guselkumab be a disease-modifying agent in plaque psoriasis?
SAN DIEGO – Questions remain about why some patients maintain durable response.
Conference Coverage
Ustekinumab quells aortic inflammation in patients with severe psoriasis
SAN DIEGO – The benefit may be a class-associated effect.
News
Biologics have best chance of achieving PASI 90 in psoriasis
Results derived from a meta-analysis of 109 randomized, controlled trials contrast with real-world treatment recommendations.
Conference Coverage
Experts review the year in rheumatology ... and what lies ahead
Thought leaders pick rheumatology’s top developments in the past year and predict the big events to come at the Rheumatology Winter Clinical...
Conference Coverage
Risankizumab outpaced ustekinumab for complete clearance of plaque psoriasis
Latest News
Here comes bimekizumab, the newest IL-17 inhibitor
KAUAI, HAWAII – “If this holds up in phase 3, it’s going to be a new world for our patients and for us, ” said Craig L. Leonardi, MD.
News
ACR sounds more welcoming tone in new biosimilars position paper
But in a related editorial Dr. Roy Fleischmann notes that there are still many concerns regarding biosimilars.
Conference Coverage
Get ready for certolizumab for psoriasis
KAUAI, HAWAII – Women of childbearing potential may prefer it.